Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joshua M Diamond

Showing results (121-130 of 145) with videos related to

Pageof 15
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 15, 2012
A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantationRupal J Shah, Scarlett L Bellamy, A Russell Localio, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 27, 2021
Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung diseaseJake G Natalini, Joshua M Diamond, Mary K Porteous, et al.
American Journal of Respiratory and Critical Care Medicine|January 29, 2014
Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunctionJoshua M Diamond, Tatiana Akimova, Altaf Kazi, et al.
Annals of the American Thoracic Society|April 12, 2017
Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical IllnessMatthew R Baldwin, Jonathan P Singer, Debbie Huang, et al.
American Journal of Respiratory and Critical Care Medicine|July 24, 2012
Variation in PTX3 is associated with primary graft dysfunction after lung transplantationJoshua M Diamond, Nuala J Meyer, Rui Feng, et al.
Plos One|January 4, 2013
Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantationJoshua M Diamond, Mary K Porteous, Edward Cantu, et al.
Annals of the American Thoracic Society|July 19, 2017
Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary HypertensionMary K Porteous, James C Lee, David J Lederer, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2013
Clinical risk factors for primary graft dysfunction after lung transplantationJoshua M Diamond, James C Lee, Steven M Kawut, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 10, 2016
The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxiaJoshua M Diamond, Mary K Porteous, L Jackson Roberts, et al.
American Journal of Respiratory and Critical Care Medicine|September 6, 2017
Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung TransplantEdward Cantu, Joshua M Diamond, Yoshikazu Suzuki, et al.
Pageof 15

Showing results (121-130 of 145) with videos related to

Sort By:
Pageof 15
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 15, 2012
A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantationRupal J Shah, Scarlett L Bellamy, A Russell Localio, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 27, 2021
Risk of primary graft dysfunction following lung transplantation in selected adults with connective tissue disease-associated interstitial lung diseaseJake G Natalini, Joshua M Diamond, Mary K Porteous, et al.
American Journal of Respiratory and Critical Care Medicine|January 29, 2014
Genetic variation in the prostaglandin E2 pathway is associated with primary graft dysfunctionJoshua M Diamond, Tatiana Akimova, Altaf Kazi, et al.
Annals of the American Thoracic Society|April 12, 2017
Refining Low Physical Activity Measurement Improves Frailty Assessment in Advanced Lung Disease and Survivors of Critical IllnessMatthew R Baldwin, Jonathan P Singer, Debbie Huang, et al.
American Journal of Respiratory and Critical Care Medicine|July 24, 2012
Variation in PTX3 is associated with primary graft dysfunction after lung transplantationJoshua M Diamond, Nuala J Meyer, Rui Feng, et al.
Plos One|January 4, 2013
Elevated plasma angiopoietin-2 levels and primary graft dysfunction after lung transplantationJoshua M Diamond, Mary K Porteous, Edward Cantu, et al.
Annals of the American Thoracic Society|July 19, 2017
Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary HypertensionMary K Porteous, James C Lee, David J Lederer, et al.
American Journal of Respiratory and Critical Care Medicine|January 12, 2013
Clinical risk factors for primary graft dysfunction after lung transplantationJoshua M Diamond, James C Lee, Steven M Kawut, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 10, 2016
The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxiaJoshua M Diamond, Mary K Porteous, L Jackson Roberts, et al.
American Journal of Respiratory and Critical Care Medicine|September 6, 2017
Quantitative Evidence for Revising the Definition of Primary Graft Dysfunction after Lung TransplantEdward Cantu, Joshua M Diamond, Yoshikazu Suzuki, et al.
Pageof 15